Suraj Kalia analyst OPPENHEIMER

Currently out of the existing stock ratings of Suraj Kalia, 100 are a BUY (68.97%), 20 are a HOLD (13.79%), 25 are a SELL (17.24%).

Suraj Kalia

Work Performance Price Targets & Ratings Chart

Analyst Suraj Kalia, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 47.92% that have a potential upside of 35.71% achieved within 172 days.

Suraj Kalia’s has documented 330 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ATRC, AtriCure at 30-Oct-2024.

Wall Street Analyst Suraj Kalia

Analyst best performing recommendations are on ISR (ISORAY).
The best stock recommendation documented was for ATRC (ATRICURE) at 4/28/2021. The price target of $75 was fulfilled within 1 day with a profit of $5.15 (7.37%) receiving and performance score of 73.73.

Average potential price target upside

ABMD ABIOMED ATRC AtriCure BLFS BioLife Solutions CRY CryoLife CSII Cardiovascular Systems EW Edwards Lifesciences Corp INSP Inspire Medical Systems IRTC iRhythm Technologies ISR IsoRay ISRG Intuitive Surgical NVRO Nevro Corp RMD ResMed TCMD Tactile Systems Technology TMDX TransMedics Group VRAY ViewRay APEN Apollo Endosurgery DXCM DexCom PODD Insulet HUMA Humacyte AORT Artivion IRT Independence Realty Trust NYXH Nyxoah SWAV Shockwave Medical VREX Varex Imaging Corp BFLY Butterfly Network TMDI Titan Medical VERO Venus Concept XAIR Beyond Air XENT Intersect ENT RSLS ReShape Lifesciences SILK Silk Road Medical

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$388

$6.98 (1.83%)

$355

2 years 6 days ago
(02-Nov-2022)

2/5 (40%)

$14.49 (3.88%)

88

Hold

$380

$-1.02 (-0.27%)

$235

2 years 6 days ago
(02-Nov-2022)

1/2 (50%)

$6.49 (1.74%)

36

Hold

$380

$-1.02 (-0.27%)

$350

2 years 7 days ago
(01-Nov-2022)

24/41 (58.54%)

$2.18 (0.58%)

138

Buy

$300

$-81.02 (-21.26%)

$425

2 years 27 days ago
(12-Oct-2022)

1/2 (50%)

$57.23 (23.57%)

20

Sell

$235

$-146.02 (-38.32%)

$275

2 years 3 months 24 days ago
(15-Jul-2022)

6/8 (75%)

$-33.23 (-12.39%)

142

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Suraj Kalia is most bullish on?

Potential upside of $69.96 has been obtained for IRTC (IRHYTHM TECHNOLOGIES)

Which stock is Suraj Kalia is most reserved on?

Potential downside of -$0 has been obtained for RMD (RESMED)

What Year was the first public recommendation made by Suraj Kalia?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?